Charles Reilly
Ophthalmology · San Antonio, TXNPI 1326026626
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 13 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Carl Zeiss Meditec, Inc. at 37.1% of the total. Reporting peaked in 2020 at $95 and has fallen 62.1% since, to $36 in 2023. That places this record below the midpoint for ophthalmology clinicians in TX, where the typical reported total is $1,835.
Across 13 payments — averaging $23.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Carl Zeiss Meditec, Inc.$116
- Biotissue Holdings Inc.$55
- Alcon$39
- Ocular Therapeutix, Inc.$33
- Akorn, Inc.$23
- Sun Pharmaceutical Industries Inc.$17
- plus $28 from 2 others
Across 51 payments — averaging $4855.98 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Glaukos Corporation$97K
- Oyster Point Pharma, Inc.$74K
- Alcon Research LLC$32K
- Johnson & Johnson Surgical Vision, Inc.$28K
- Sun Pharmaceutical Industries Inc.$16K
- Osmotica Pharmaceutical Corp.$2K
What the payments were for
- Food & beverage$312100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Carl Zeiss Meditec, Inc. | 2 | $116 |
| Biotissue Holdings Inc. | 3 | $55 |
| Alcon | 2 | $39 |
| Ocular Therapeutix, Inc. | 2 | $33 |
| Akorn, Inc. | 1 | $23 |
| Sun Pharmaceutical Industries Inc. | 1 | $17 |
| AbbVie | 1 | $15 |
| Novartis | 1 | $13 |
How this compares
$312 in reported general payments places this provider in the 20th percentile of 1,355 ophthalmology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 12 | $346 |
| Latanoprost | 13 | $125 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in San Antonio
- Michael SingerSan Antonio$1.8M
- Gregory ParkhurstSan Antonio$185K
- James LehmannSan Antonio$162K
- Oluwatosin SmithDallas$1.5M
- Charles WykoffBellaire$1.5M
- John MichelettiHouston$916K
- Davinder GroverDallas$705K
- Christina WengHouston$676K
- Peter ChangHouston$656K
- Zaina Al-MohtasebHouston$636K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.